600664.SS
600664.SS
CNE0000009T3
HARBIN PHARMACEUTICAL GROUP CO
Loading chart...

Company Profile

Harbin Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, wholesale, and retail of pharmaceuticals in China and internationally. The company offers pharmaceutical products for respiratory, chronic, digestive, blood and hematopoietic, anti-tumor and immunomodulatory, anti-inflammatory and analgesic, antiviral and anti-infective, cerebrovascular, and cardiovascular diseases, as well as mineral and nutritional supplements, and antibiotics. It also provides calcium iron zinc oral solutions, zinc gluconate oral solutions, compound calcium gluconate oral solutions, Shuanghuanglian oral solutions, amoxicillin capsules, human erythropoietin injections, iron and vitamin B12 oral solutions, calcium, iron, and zinc oral solutions, ceftriaxone sodium injections, Qufenggutong gel ointment, GNC Vitapak nutritional pack, lacidipine tablets, GNC fish oil capsules, coenzyme Q10 and panthenol soft capsules, GNC children's liquid calcium magnesium zinc, penicillin sodium, acetaminophen and chlorpheniramine maleate granules, glucosamine chondroitin calcium tablets, ceftriaxone sodium for injection, GNC milk thistle extract tablets and capsules, and compound sulfamethoxazole oral tablets. The company is also involved in culture, science and technology, pharmaceutical commercial and industry, property, and investment activities. Harbin Pharmaceutical Group Co., Ltd. was founded in 1991 and is based in Harbin, China.

Related stocks

600380.SS
600380.SS • China
JOINCARE PHARMACEUTICAL GROUP I
10.13 CNY
2.77B USD 1Y -19.3%
1513.HK
1513.HK • China
LIVZON PHARMA
22.16 HKD
2.51B USD 1Y -35.7%
600062.SS
600062.SS • China
CHINA RESOURCES DOUBLE-CRANE PH
16.44 CNY
2.55B USD 1Y -13.1%
600566.SS
600566.SS • China
HUBEI JUMPCAN PHARMACEUTICAL CO
26.7 CNY
3.68B USD 1Y +8.3%
600867.SS
600867.SS • China
TONGHUA DONGBAO MEDICINES CO LT
7.88 CNY
2.31B USD 1Y -7%
600535.SS
600535.SS • China
TASLY PHARMACEUTICAL GROUP CO L
14.2 CNY
3.17B USD 1Y -10.3%
603456.SS
603456.SS • China
ZHEJIANG JIUZHOU PHARMACEUTICAL
16.31 CNY
2.14B USD 1Y -20.9%
000513.SZ
000513.SZ • China
LIVZON GROUP
30.5 CNY
4.05B USD 1Y -21.4%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
39.4% p.a.
Max Drawdown (5Y)
-38.0%
Sharpe Ratio (5Y)
0.35
Beta Factor
0.06
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Elevated Short-Term Volatility: 3Y volatility (43.9%) is noticeably higher than the 5Y average (39.4%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (39.4% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -75.2% in the extended horizon.
ende